questionsmedicales.fr
Systèmes sanguin et immunitaire
Système immunitaire
Leucocytes
Agranulocytes
Lymphocytes
Lymphocytes T
Sous-populations de lymphocytes T
Lymphocytes T cytotoxiques
Lymphocytes T cytotoxiques : Questions médicales fréquentes
Diagnostic
5
Déficience immunitaire
Lymphocytes T
Tests immunologiques
Cytotoxicité
Cytokines
Tests immunologiques
Lymphocytes T
Analyse sanguine
Immunophénotypage
Marqueurs cellulaires
Lymphocytes T
CD8
Réponse immunitaire
Cytokines
Prolifération cellulaire
Symptômes
5
Infections
Fatigue
Maladies auto-immunes
Santé mentale
Infections
Lymphocytes T
Fièvre
Inflammation
Éruptions cutanées
Allergies
Lymphocytes T
Réaction immunitaire
Tumeurs
Cytotoxicité
Lymphocytes T
Prévention
5
Prévention des infections
Vaccination
Hygiène
Régime alimentaire
Nutriments
Système immunitaire
Stress
Immunité
Lymphocytes T
Sommeil
Réponse immunitaire
Lymphocytes T
Compléments alimentaires
Vitamine D
Lymphocytes T
Traitements
5
Immunothérapie
Inhibiteurs de points de contrôle
Lymphocytes T
Vaccins
Réponse immunitaire
Lymphocytes T
Transfusions
Thérapie cellulaire
Cancer
Corticostéroïdes
Immunosuppresseurs
Lymphocytes T
Thérapie génique
Lymphocytes T
Cancer
Complications
5
Infections opportunistes
Cancer
Déficience immunitaire
Maladies auto-immunes
Lymphocytes T
Activation immunitaire
Greffe d'organe
Rejet
Lymphocytes T
Allergies
Réponse immunitaire
Lymphocytes T
Suractivation
Maladies inflammatoires
Lymphocytes T
Facteurs de risque
5
Âge avancé
Diabète
Immunosuppression
Tabagisme
Lymphocytes T
Immunité
Maladies chroniques
VIH
Lymphocytes T
Toxines
Lymphocytes T
Fonction immunitaire
Stress psychologique
Lymphocytes T
Infections
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lymphocytes T cytotoxiques : Questions médicales les plus fréquentes",
"headline": "Lymphocytes T cytotoxiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lymphocytes T cytotoxiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-19",
"dateModified": "2026-04-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lymphocytes T cytotoxiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Sous-populations de lymphocytes T",
"url": "https://questionsmedicales.fr/mesh/D016176",
"about": {
"@type": "MedicalCondition",
"name": "Sous-populations de lymphocytes T",
"code": {
"@type": "MedicalCode",
"code": "D016176",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A15.382.490.555.567.569.500"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Lymphocytes T cytotoxiques",
"alternateName": "T-Lymphocytes, Cytotoxic",
"code": {
"@type": "MedicalCode",
"code": "D013602",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jens Rettig",
"url": "https://questionsmedicales.fr/author/Jens%20Rettig",
"affiliation": {
"@type": "Organization",
"name": "Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Homburg, Germany."
}
},
{
"@type": "Person",
"name": "Markus Hoth",
"url": "https://questionsmedicales.fr/author/Markus%20Hoth",
"affiliation": {
"@type": "Organization",
"name": "Department of Biophysics, Center for Integrative Physiology and Molecular Medicine, Medical Faculty, Saarland University, Homburg, Germany. Electronic address: markus.hoth@uks.eu."
}
},
{
"@type": "Person",
"name": "Gillian M Griffiths",
"url": "https://questionsmedicales.fr/author/Gillian%20M%20Griffiths",
"affiliation": {
"@type": "Organization",
"name": "Cambridge Institute for Medical Research, Keith Peters Building, Cambridge CB2 0XY, UK."
}
},
{
"@type": "Person",
"name": "Keerthana Ravichandran",
"url": "https://questionsmedicales.fr/author/Keerthana%20Ravichandran",
"affiliation": {
"@type": "Organization",
"name": "Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Homburg, Germany."
}
},
{
"@type": "Person",
"name": "Elmar Krause",
"url": "https://questionsmedicales.fr/author/Elmar%20Krause",
"affiliation": {
"@type": "Organization",
"name": "Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Homburg, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cytotoxic T lymphocytes require transcription for infiltration but not target cell lysis.",
"datePublished": "2023-10-20",
"url": "https://questionsmedicales.fr/article/37860838",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.15252/embr.202357653"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impaired CD4+ Cytotoxic T Lymphocyte Activity in Polyomavirus BK Infected Kidney Transplant Recipients.",
"datePublished": "2023-09-03",
"url": "https://questionsmedicales.fr/article/37767680",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.18502/ijaai.v22i4.13610"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cytotoxic T-lymphocyte-associated protein 4 +49A/G polymorphism in Down syndrome children with Hashimoto's thyroiditis.",
"datePublished": "2023-07-03",
"url": "https://questionsmedicales.fr/article/36724016",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.17305/bb.2022.7869"
}
},
{
"@type": "ScholarlyArticle",
"name": "LMO2 attenuates glycolytic metabolism and facilitates cytotoxic T-lymphocyte infiltration in the tumor environment of lung and breast cancers.",
"datePublished": "2023-07-18",
"url": "https://questionsmedicales.fr/article/37480698",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bbrc.2023.07.024"
}
},
{
"@type": "ScholarlyArticle",
"name": "The pathogenic response of cytotoxic T‑lymphocytes, a common therapeutic target for cancer, has a direct impact on treatment outcomes (Review).",
"datePublished": "2024-06-21",
"url": "https://questionsmedicales.fr/article/38904200",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3892/or.2024.8757"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Systèmes sanguin et immunitaire",
"item": "https://questionsmedicales.fr/mesh/D006424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007107"
},
{
"@type": "ListItem",
"position": 4,
"name": "Leucocytes",
"item": "https://questionsmedicales.fr/mesh/D007962"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agranulocytes",
"item": "https://questionsmedicales.fr/mesh/D007963"
},
{
"@type": "ListItem",
"position": 6,
"name": "Lymphocytes",
"item": "https://questionsmedicales.fr/mesh/D008214"
},
{
"@type": "ListItem",
"position": 7,
"name": "Lymphocytes T",
"item": "https://questionsmedicales.fr/mesh/D013601"
},
{
"@type": "ListItem",
"position": 8,
"name": "Sous-populations de lymphocytes T",
"item": "https://questionsmedicales.fr/mesh/D016176"
},
{
"@type": "ListItem",
"position": 9,
"name": "Lymphocytes T cytotoxiques",
"item": "https://questionsmedicales.fr/mesh/D013602"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lymphocytes T cytotoxiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lymphocytes T cytotoxiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lymphocytes T cytotoxiques",
"description": "Comment diagnostiquer une déficience en T-Lymphocytes cytotoxiques ?\nQuels tests évaluent l'activité des T-Lymphocytes cytotoxiques ?\nPeut-on mesurer les T-Lymphocytes cytotoxiques dans le sang ?\nQuels marqueurs sont utilisés pour identifier les T-Lymphocytes cytotoxiques ?\nComment évaluer la réponse immunitaire des T-Lymphocytes ?",
"url": "https://questionsmedicales.fr/mesh/D013602#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lymphocytes T cytotoxiques",
"description": "Quels symptômes indiquent une défaillance des T-Lymphocytes ?\nLes T-Lymphocytes cytotoxiques affectent-ils la santé mentale ?\nQuels signes cliniques révèlent une activation des T-Lymphocytes ?\nLes T-Lymphocytes cytotoxiques causent-ils des symptômes allergiques ?\nComment les T-Lymphocytes cytotoxiques affectent-ils les tumeurs ?",
"url": "https://questionsmedicales.fr/mesh/D013602#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lymphocytes T cytotoxiques",
"description": "Comment prévenir les infections liées aux T-Lymphocytes ?\nLes régimes alimentaires influencent-ils les T-Lymphocytes ?\nLe stress affecte-t-il les T-Lymphocytes ?\nComment le sommeil impacte-t-il les T-Lymphocytes ?\nLes compléments alimentaires aident-ils les T-Lymphocytes ?",
"url": "https://questionsmedicales.fr/mesh/D013602#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lymphocytes T cytotoxiques",
"description": "Quels traitements renforcent les T-Lymphocytes cytotoxiques ?\nComment les vaccins influencent-ils les T-Lymphocytes ?\nLes transfusions de T-Lymphocytes sont-elles possibles ?\nQuels médicaments ciblent les T-Lymphocytes cytotoxiques ?\nComment la thérapie génique affecte-t-elle les T-Lymphocytes ?",
"url": "https://questionsmedicales.fr/mesh/D013602#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lymphocytes T cytotoxiques",
"description": "Quelles complications peuvent survenir avec des T-Lymphocytes défaillants ?\nLes T-Lymphocytes peuvent-ils causer des maladies auto-immunes ?\nComment les T-Lymphocytes affectent-ils la greffe d'organe ?\nLes T-Lymphocytes sont-ils impliqués dans les allergies ?\nQuelles sont les conséquences d'une suractivation des T-Lymphocytes ?",
"url": "https://questionsmedicales.fr/mesh/D013602#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lymphocytes T cytotoxiques",
"description": "Quels facteurs augmentent le risque d'infections liées aux T-Lymphocytes ?\nLe tabagisme affecte-t-il les T-Lymphocytes ?\nLes maladies chroniques influencent-elles les T-Lymphocytes ?\nL'exposition à des toxines affecte-t-elle les T-Lymphocytes ?\nLe stress psychologique influence-t-il les T-Lymphocytes ?",
"url": "https://questionsmedicales.fr/mesh/D013602#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en T-Lymphocytes cytotoxiques ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins mesurant les niveaux de lymphocytes T et des tests fonctionnels sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests évaluent l'activité des T-Lymphocytes cytotoxiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de cytotoxicité, comme le test de libération de cytokines, évaluent leur activité."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer les T-Lymphocytes cytotoxiques dans le sang ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, par des analyses de sang qui quantifient les sous-populations de lymphocytes T."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont utilisés pour identifier les T-Lymphocytes cytotoxiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs CD8+ sont typiquement utilisés pour identifier ces lymphocytes."
}
},
{
"@type": "Question",
"name": "Comment évaluer la réponse immunitaire des T-Lymphocytes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "On utilise des tests de prolifération cellulaire et de production de cytokines."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une défaillance des T-Lymphocytes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Infections fréquentes, fatigue persistante et maladies auto-immunes peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les T-Lymphocytes cytotoxiques affectent-ils la santé mentale ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, par le biais d'infections chroniques qui peuvent influencer l'humeur."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques révèlent une activation des T-Lymphocytes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, inflammation et éruptions cutanées peuvent indiquer une activation immunitaire."
}
},
{
"@type": "Question",
"name": "Les T-Lymphocytes cytotoxiques causent-ils des symptômes allergiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils ne sont pas directement responsables des allergies, mais d'autres lymphocytes le sont."
}
},
{
"@type": "Question",
"name": "Comment les T-Lymphocytes cytotoxiques affectent-ils les tumeurs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils reconnaissent et détruisent les cellules tumorales, limitant la croissance des tumeurs."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections liées aux T-Lymphocytes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vaccination, hygiène et un mode de vie sain renforcent le système immunitaire."
}
},
{
"@type": "Question",
"name": "Les régimes alimentaires influencent-ils les T-Lymphocytes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en nutriments peut soutenir la fonction immunitaire."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il les T-Lymphocytes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut diminuer leur efficacité et affaiblir l'immunité."
}
},
{
"@type": "Question",
"name": "Comment le sommeil impacte-t-il les T-Lymphocytes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un sommeil adéquat est crucial pour maintenir une réponse immunitaire optimale."
}
},
{
"@type": "Question",
"name": "Les compléments alimentaires aident-ils les T-Lymphocytes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains compléments, comme la vitamine D, peuvent soutenir leur fonction immunitaire."
}
},
{
"@type": "Question",
"name": "Quels traitements renforcent les T-Lymphocytes cytotoxiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les immunothérapies, comme les inhibiteurs de points de contrôle, stimulent leur activité."
}
},
{
"@type": "Question",
"name": "Comment les vaccins influencent-ils les T-Lymphocytes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins peuvent activer les T-Lymphocytes cytotoxiques pour combattre les infections."
}
},
{
"@type": "Question",
"name": "Les transfusions de T-Lymphocytes sont-elles possibles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des thérapies cellulaires adoptives transfusent des T-Lymphocytes pour traiter le cancer."
}
},
{
"@type": "Question",
"name": "Quels médicaments ciblent les T-Lymphocytes cytotoxiques ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes et les agents immunosuppresseurs peuvent inhiber leur fonction."
}
},
{
"@type": "Question",
"name": "Comment la thérapie génique affecte-t-elle les T-Lymphocytes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut modifier les T-Lymphocytes pour améliorer leur capacité à cibler les cellules cancéreuses."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des T-Lymphocytes défaillants ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Infections opportunistes et cancers peuvent se développer en raison d'une immunité affaiblie."
}
},
{
"@type": "Question",
"name": "Les T-Lymphocytes peuvent-ils causer des maladies auto-immunes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activation inappropriée peut entraîner des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Comment les T-Lymphocytes affectent-ils la greffe d'organe ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer le rejet de greffe en attaquant les cellules étrangères."
}
},
{
"@type": "Question",
"name": "Les T-Lymphocytes sont-ils impliqués dans les allergies ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, car une réponse immunitaire inappropriée peut contribuer aux allergies."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une suractivation des T-Lymphocytes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une suractivation peut entraîner des maladies inflammatoires et des dommages tissulaires."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infections liées aux T-Lymphocytes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, le diabète et l'immunosuppression augmentent le risque d'infections."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il les T-Lymphocytes ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut altérer la fonction des T-Lymphocytes et affaiblir l'immunité."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques influencent-elles les T-Lymphocytes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le VIH ou le cancer peuvent réduire leur nombre et leur fonction."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines affecte-t-elle les T-Lymphocytes ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines toxines environnementales peuvent compromettre leur fonction immunitaire."
}
},
{
"@type": "Question",
"name": "Le stress psychologique influence-t-il les T-Lymphocytes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress psychologique peut diminuer leur efficacité et augmenter le risque d'infections."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 09/04/2026
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Homburg, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
3 publications dans cette catégorie
Affiliations :
Department of Biophysics, Center for Integrative Physiology and Molecular Medicine, Medical Faculty, Saarland University, Homburg, Germany. Electronic address: markus.hoth@uks.eu.
Publications dans "Lymphocytes T cytotoxiques" :
3 publications dans cette catégorie
Affiliations :
Cambridge Institute for Medical Research, Keith Peters Building, Cambridge CB2 0XY, UK.
Publications dans "Lymphocytes T cytotoxiques" :
3 publications dans cette catégorie
Affiliations :
Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Homburg, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
3 publications dans cette catégorie
Affiliations :
Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Homburg, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
3 publications dans cette catégorie
Affiliations :
Department of Life Sciences, University of Siena, 53100, Siena, Italy.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Biophysics, Center for Integrative Physiology and Molecular Medicine (CIPMM), School of Medicine, Saarland University, Homburg, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Biophysics, Center for Integrative Physiology and Molecular Medicine (CIPMM), School of Medicine, Saarland University, Homburg, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Biophysics, Center for Integrative Physiology and Molecular Medicine (CIPMM), School of Medicine, Saarland University, Homburg, Germany.
INM - Leibniz Institute for New Materials, Saarbrücken, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Homburg, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Homburg, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Department of Biophysics, Center for Integrative Physiology and Molecular Medicine, Medical Faculty, Saarland University, Homburg, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Department of Biophysics, Center for Integrative Physiology and Molecular Medicine, Medical Faculty, Saarland University, Homburg, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Cambridge Institute for Medical Research, Keith Peters Building, Cambridge CB2 0XY, UK.
Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Pharmacology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, China.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Center for Hematology and Regenerative Medicine (HERM), Karolinska Institute, Stockholm, Sweden.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Neurovirology Laboratory, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Neurovirology Laboratory, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Neurovirology Laboratory, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
3-107 Microbiology Research Facility, University of Minnesota, 689 23rd Avenue S.E., Minneapolis, MN 55455, USA.
Publications dans "Lymphocytes T cytotoxiques" :
Effector cytotoxic T lymphocytes (CTLs) are critical for ridding the body of infected or cancerous cells. CTL T cell receptor (TCR) ligation not only drives the delivery and release of cytolytic granu...
The reactivation of polyomavirus BK (BKPyV) contributes to increased morbidity and mortality rates of transplant patients, especially kidney transplant recipients (KTRs). CD4+ T cells are important im...
Thyroid dysfunction is the most common endocrine disorder in Down syndrome (DS) children. Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) is one of the immune regulatory genes that correlates wit...
Aerobic glycolysis preferentially exists in many cancer cells. LMO2 is an adaptor protein ubiquitously expressed in many epithelia and their malignancies, and it mediates broad-spectrum protein intera...
Cytotoxic T lymphocytes (CTLs), also known as CD8...
Advances in understanding the pathological mechanisms of breast cancer have resulted in the emergence of novel therapeutic strategies. However, triple-negative breast cancer (TNBC), a molecular subtyp...
Neoantigen-reactive cytotoxic T lymphocytes play a vital role in precise cancer cell elimination. In this study, we demonstrate the effectiveness of personalized neoantigen-based T cell therapy in ind...
Both genetic susceptibility and environmental exposures are thought to be involved in multiple sclerosis (MS) pathogenesis. Of all viruses potentially relevant to MS aetiology, Epstein-Barr virus (EBV...
Photoactivated immunotherapy has promising therapeutic efficacy for treating malignancies, especially metastatic tumors. In this study, an erythrocyte membrane-encapsulated copper indium selenium (RCI...
Acquired idiopathic generalized anhidrosis (AIGA) leads to heat intolerance due to the loss or reduction in thermoregulatory sweating over an extensive area of the body. The pathomechanism of AIGA is ...
We investigated the clinical and pathological features of inflammatory AIGA (InfAIGA) and noninflammatory AIGA (non-InfAIGA) within the skin....
We compared anhidrotic and normohidrotic skin samples from 30 patients with InfAIGA and non-InfAIGA, as well as skin samples of melanocytic nevus as a negative control. We conducted morphometric analy...
We found that tissue samples from patients with InfAIGA exhibited inflammation within the sweat duct and atrophy of the sweat coil, whereas patients with non-InfAIGA exhibited only atrophy of the swea...
InfAIGA is associated with increased sweat duct inflammation and sweat coil atrophy, whereas non-InfAIGA is only associated with sweat coil atrophy. These data suggest that inflammation leads to epith...